Gap junction modifiers regulate electrical activities of the sinoatrial node and pulmonary vein: Therapeutic implications in atrial arrhythmogenesis

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 529-536

  Chang, Chien Jung ^a   Cheng, Chen Chuan ^b,c   Chen, Yao Chang ^d   Kao, Yu Hsun ^e   Chen, Shih Ann ^f,g   Chen, Yi Jen ^e,h  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; Gap junction; Pacemaker current; PQ1; Pulmonary vein; Sinoatrial node

Indexed keywords

HEPTANOL; ISOPRENALINE; AMINOQUINOLINE DERIVATIVE; CARDIOVASCULAR AGENT; PQ1 COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; ELECTRIC ACTIVITY; FIRING RATE; GAP JUNCTION; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; RABBIT; SINUS NODE; WHOLE CELL PATCH CLAMP; ACTION POTENTIAL; ANIMAL; ATRIAL FIBRILLATION; DRUG EFFECTS; HEART ATRIUM; LEPORIDAE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTION POTENTIALS; AMINOQUINOLINES; ANIMALS; ATRIAL FIBRILLATION; CARDIOVASCULAR AGENTS; GAP JUNCTIONS; HEART ATRIA; HEPTANOL; ISOPROTERENOL; MYOCYTES, CARDIAC; PULMONARY VEINS; RABBITS; SINOATRIAL NODE;

EID: 84978066757     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.027     Document Type: Article

References (40)

1. [1] Benjamin, E.J., Wolf, P.A., D'Agostino, R.B., Silbershatz, H., Kannel, W.B., Levy, D., Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998), 946–952.
2. [2] Chen, Y.J., Chen, S.A., Chang, M.S., Lin, C.I., Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc. Res. 48 (2000), 265–273.
3. [3] Haissaguerre, M., Jais, P., Shah, D.C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A.L., Metayer, P.L., Clementy, J., Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339 (1998), 659–666.
4. [4] Chen, S.A., Hsieh, M.H., Tai, C.T., Tsai, C.F., Prakash, V.S., Yu, W.C., Hsu, T.L., Ding, Y.A., Chang, M.S., Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 (1999), 1879–1886.
5. [5] Chen, Y.J., Chen, S.A., Electrophysiology of pulmonary veins. J. Cardiovasc. Electrophysiol. 17 (2006), 220–224.
6. [6] Fedorov, V.V., Chang, R., Glukhov, A.V., Kostecki, G., Janks, D., Schuessler, R.B., Efimov, I.R., Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart. Circulation 122 (2010), 782–789.
7. [7] Li, G., Liu, E., Liu, T., Wang, J., Dai, J., Xu, G., Korantzopoulos, P., Yang, W., Atrial electrical remodeling in a canine model of sinus node dysfunction. Int. J. Cardiol. 146 (2011), 32–36.
8. [8] Chang, H.Y., Lin, Y.J., Lo, L.W., Chang, S.L., Hu, Y.F., Li, C.H., Chao, T.F., Yin, W.H., Chen, S.A., Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodeling. Europace 15 (2013), 205–211.
9. [9] Severs, N.J., Coppen, S.R., Dupont, E., Yeh, H.I., Ko, Y.S., Matsushita, T., Gap junction alterations in human cardiac disease. Cardiovasc. Res. 62 (2004), 368–377.
10. [10] Mezzano, V., Sheikh, F., Cell–cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias?. Life Sci. 27 (2012), 313–321.
11. [11] Severs, N.J., Dupont, E., Thomas, N., Kaba, R., Rothery, S., Jain, R., Sharpey, K., Fry, C.H., Alterations in cardiac connexin expression in cardiomyopathies. Adv. Cardiol. 42 (2006), 228–242.
12. [12] Ohara, T., Qu, Z., Lee, M.H., Ohara, K., Omichi, C., Mandel, M.J., Chen, P.S., Karagueuzian, H.S., Increased vulnerability to inducible atrial fibrillation caused by partial cellular uncoupling with heptanol. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H1116–H1122.
13. [13] Laurent, G., Leong-Poi, H., Mangat, I., Moe, G.W., Hu, X., So, P.P., Tarulli, E., Ramadeen, A., Rossman, E.I., Hennan, J.K., Dorian, P., Effects of chronic gap junction conduction–enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs. Circ. Arrhythm. Electrophysiol. 2 (2009), 171–178.
14. [14] Guerra, J.M., Everett, T.H. IV, Lee, K.W., Wilson, E., Olgin, J.E., Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 114 (2006), 110–118.
15. [15] Sohl, G., Willecke, K., Gap junctions and the connexin protein family. Cardiovasc. Res. 62 (2004), 228–232.
16. [16] Giovannone, S., Remo, B.F., Fishman, G.I., Channeling diversity: gap junction expression in the heart. Heart Rhythm. 9 (2012), 1159–1162.
17. [17] De Vuyst, E., Boengler, K., Antoons, G., Sipido, K.R., Schulz, R., Leybaert, L., Pharmacological modulation of connexin-formed channels in cardiac pathophysiology. Br. J. Pharmacol. 163 (2011), 469–483.
18. [18] Verkerk, A.O., Veldkamp, M.W., Coronel, R., Wilders, R., Ginneken, A.C.G., Effects of cell-to-cell uncoupling and catecholamines on Purkinje and ventricular action potentials: implications for phase-1b arrhythmias. Cardiovasc. Res. 51 (2001), 30–40.
19. [19] Tse, G., Hothi, S.S., Grace, A.A., Huang, C.L.H., Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts. J. Physiol. Sci. 62 (2012), 79–92.
20. [20] Verheule, S., Wilson, E.E., Arora, R., Engle, S.K., Scott, L.R., Olgin, J.E., Tissue structure and connexion expression of canine pulmonary veins. Cardiovasc. Res. 55 (2002), 727–738.
21. [21] Takens-Kwak, B.R., Jongsma, H.J., Rook, M.B., Ginneken, A.C.G.V., Mechanisms of heptano-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study. Am. J. Phys. 262 (1992), C1531–C1538.
22. [22] Garcia-Dorado, D., Inserte, J., Ruiz-Meana, M., Gonzalez, M.A., Solares, J., Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96 (1997), 3579–3586.
23. [23] Ding, Y., Prasain, K., Nguyen, T.D.T., Hua, D.H., Nguyen, T.A., The effect of the PQ1 anti-breast cancer agent on normal tissues. Anti-Cancer Drugs 23 (2012), 897–905.
24. [24] Bigelow, K., Nguyen, T.A., PQ1: increase of gap junction activities in SW480 human colorectal cancer cells. BMC Cancer, 14, 2014, 502.
25. [25] Chang, C.J., Chen, Y.C., Kao, Y.H., Lin, Y.K., Chen, S.A., Chen, Y.J., Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium. Circ. Arrhythm. Electrophysiol. 5 (2012), 1176–1183.
26. [26] Chang, C.J., Chen, Y.C., Lin, Y.K., Huang, J.H., Chen, S.A., Chen, Y.J., Rivaroxaban modulates electrical and mechanical characteristics of left atrium. J. Biomed. Sci., 20, 2013, 17.
27. [27] Chen, Y.C., Pan, N.H., Cheng, C.C., Higa, S., Chen, Y.J., Chen, S.A., Heterogeneous expression of potassium currents and pacemaker currents potentially regulates arrhythmogenesis of pulmonary vein cardiomyocytes. J. Cardiovasc. Electrophysiol. 20 (2009), 1309–1345.
28. [28] Dobrzynski, H., Boyett, M.R., Anderson, R.H., New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115 (2007), 1921–1932.
29. [29] Hayashi, H., Does remodeling of gap junctions and connexin expression contribute to arrhythmogenesis? Study in an immobilization rat model. Circ. J. 74 (2010), 2558–2559.
30. [30] Yeh, H.I., Lai, Y.J., Lee, S.H., Lee, Y.N., Ko, Y.S., Chen, S.A., Severs, N.J., Tsai, C.H., Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation 104 (2001), 3152–3157.
31. [31] Chen, Y.C., Lu, Y.Y., Cheng, C.C., Lin, Y.K., Chen, S.A., Chen, Y.J., Sinoatrial node electrical activity modulates pulmonary vein arrhythmogenesis. Int. J. Cardiol. 173 (2014), 447–452.
32. [32] Jones, S.A., Lancaster, M.K., Boyett, M.R., Aging-related changes of connexins and conduction within the sinoatrial node. J. Physiol. 560 (2004), 429–437.
33. [33] Decrock, E., Vinken, M., Bol, M., D'Herde, K., Rogiers, V., Vandenabeele, P., Krysko, D.V., Bultynck, G., Leybaert, L., Calcium and connexin-based intercellular communication, a deadly catch?. Cell Calcium 50 (2011), 310–321.
34. [34] Stout, C.E., Costantin, J.L., Naus, C.C., Charles, A.C., Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 277 (2002), 10482–10488.
35. 2 + exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardiovasc. Res. 70 (2006), 497–508.
36. [36] Liu, M.B., Lange, E., Garfinkel, A., Weiss, J.N., Qu, Z., Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue. Heart Rhythm 12 (2015), 2115–2124.
37. [37] Hove-Madsen, L., Llach, A., Mayes-Genís, A., Roura, S., Rodriguez Font, E., Arís, A., Cinca, J., Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 110 (2004), 1358–1363.
38. [38] Peracchia, C., Chemical gating of gap junction channels: roles of calcium, pH and calmodulin. Biochim. Biophys. Acta 1662 (2004), 61–80.
39. [39] Jalife, J., Sicouri, S., Delmar, M., Michaels, D.C., Electrical uncoupling and impulse propagation in isolated sheep Purkinje fibers. Am. J. Physiol. Heart Circ. Physiol. 257 (1989), H179–H189.
40. [40] Barbuti, A., Gravante, B., Riolfo, M., Milanesi, R., Terragni, B., DiFrancesco, D., Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ. Res. 94 (2004), 1325–1331.